Anastasiya A. Bondarenko

Anastasiya A. Bondarenko

Auto-generated profile, based on publicly available information

Anastasiya A. Bondarenko

Golikov Research Clinical Center of Toxicology of the Federal Medical and Biological Agency of Russia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
ANA. M. Nosov
A. M. Nosov
ABA. A. Bondarenko
A. A. Bondarenko
GKG. G. Katretskaya
G. G. Katretskaya
KGK. P. Golovko
K. P. Golovko
ASA. V. Shultz
A. V. Shultz
OGO. N. Gaikova
O. N. Gaikova
Introduction. Hemostasis of ongoing bleeding during cavitary surgical interventions is an urgent problem both in civil and military healthcare. The development of new effective and affordable agents for hemostasis of internal bleeding and their introduction into clinical practice may contribute to increasing the survival of injured patients.Objective. Study of general and local toxic effects of a local hemostatic agent (LHA) for intracavitary application.Materials and methods. The study was performed on 20 mongrel rats (10 males and 10 females) weighing 180–220 g. The experimental group of animals was implanted with the LHA into the abdominal cavity at a dose of 512 mg/kg body weight (bw). The animals of the control group underwent surgery without LHA implantation. Data analysis was performed using the Microsoft Excel 2013 and Statistica 10.0 software applications.Results. The health status, body weight, food and water consumption, and mass coefficients of internal organs in the experimental animals did not differ from those in the control group. The hematological and biochemical blood parameters showed values within the reference norm. The macro- and microscopic examination of the internal organs revealed a local irritant effect of the agent under study.Conclusion. The laboratory animals tolerated the intraperitoneal implantation of the tested local hemostatic agent at a dose of 512 mg/kg bw well. A further study of its toxic properties and effectiveness is validated.

30 October 2023 in Toxicological Review
Verified
Journal Article
Closed access
PDF file
AMAleksandra S. Melekhova
Aleksandra S. Melekhova
ЕШЕвгений Борисович Шустов
Евгений Борисович Шустов
ВЗВероника Николаевна Зорина
Вероника Николаевна Зорина
АБАлександр Яковлевич Беспалов
Александр Яковлевич Беспалов
MMMargarita V. Mel’nIkova
Margarita V. Mel’nIkova
ABAnastasiya A. Bondarenko
Anastasiya A. Bondarenko
Introduction. Despite a significant number of antidotes (atropine, pyridoxine) and anti-seizure drugs in clinical practice (benzodiazepines, barbiturates, valproates, anesthetics), the development of new antidotes for the relief of refractory seizures and recurrence of convulsive syndrome is actual problem. The aim of the work was to study the specific pharmacological activity of a new original derivative of valproic acid in an experiment on models of convulsive syndrome with different mechanisms of action. Material and methods. A comparative study of the effectiveness of the original substance ((1-methylpiperidin-4-yl)-2-propylpentanoate hydrochloride, VAA) was carried out on electroshock, GABA-lytic, catecholamine-dependent seizure models in rats and mice. Results. A significant decrease in seizure activity was revealed in the group with prophylactic administration of VAA in the dose range of 11, 27 and 65 mg/kg in comparison with the control group received only phenylcarbamate. In an intergroup comparison, a low dose (11 mg/kg) more than others had an effect on the latent period of the onset of phenylcarbamate seizures, an average dose (27 mg/kg) reduced the duration of the seizure period, a high dose (65 mg/kg) affected the severity of convulsions, while the integral indicator (convulsive activity) did not differ between the medium and high dose subgroups. There was no significant decrease in seizure activity in models with the use of corazol, camphor, and the model of maximum electric shock. Limitations. Testing of new pharmaceutical substances (study of efficacy and safety) should be carried out on laboratory animals before confirmation of efficacy in humans. The quantity of animals was limited by the need to comply with bioethical principles and sufficient number for statistically significant results and amounted 6 individuals in each group. Conclusion. The release of valproic acid during the metabolism of VAA is slow and its concentration is insufficient to realize the universal anticonvulsant activity of VAA. It is necessary to further study the effect on cognitive functions and neuroprotective properties. Since antidote efficacy superior to atropine has been previously demonstrated, VAA is recommended for development as an antidote for organophosphorus poisoning.

17 November 2025 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
ABA. V. Belskaya
A. V. Belskaya
AMA. S. Melekhova
A. S. Melekhova
VZV. N. Zorina
V. N. Zorina
ABA. Ya. Bespalov
A. Ya. Bespalov
МММ. В. Мельникова
М. В. Мельникова
ABA. A. Bondarenko
A. A. Bondarenko
Противосудорожная активность оригинальных аминоэфиров вальпроевой кислоты при интоксикации ингибитором холинэстераз

18 December 2025 in Journal Biomed
Verified
Journal Article
Open access
PDF file
МММ. В. Мельникова
М. В. Мельникова
ESE. B. Shustov
E. B. Shustov
EBEkaterina Gennadjievna Batotsyrenova
Ekaterina Gennadjievna Batotsyrenova
LKL. G. Kubarskaya
L. G. Kubarskaya
ABA. A. Bondarenko
A. A. Bondarenko
АBА. V. Belskaya
А. V. Belskaya
The efficacy of Strongylocentrotus droebachiensis gonad lyophilisate in combined poisoning with carbendazim and X-ray irradiation was assessed in rat biomodels. Two-week intragastric administration of the lyophilisate was shown to partially compensate for the changes caused by adverse factors, as the same time as exhibiting antioxidant, hemopoetic, and anabolic aciton.

11 November 2024 in Journal Biomed
Verified
Journal Article
Open access
PDF file
МММ. В. Мельникова
М. В. Мельникова
ESE. B. Shustov
E. B. Shustov
EZEkaterina Zolotoverkhaja
Ekaterina Zolotoverkhaja
LKL. G. Kubarskaya
L. G. Kubarskaya
ABA. A. Bondarenko
A. A. Bondarenko
AVA. A. Vataeva
A. A. Vataeva
Currently, biologically active substances of natural origin are widely used as preventative agents. The search and development of new drugs for the prevention and correction of nonspecific disorders of the body’s resistance to adverse effects in environment continues. A preclinic assessment of the effectiveness of polyprenols from Siberian fir Abies sibirica was carried out when used prophylactically for two weeks. It has been shown that the effect of polyprenols is manifested by antioxidant, anabolic activity and stimulation of hematopoiesis in an experimental model of combined poisoning with carbendazim and X-ray irradiation.

5 April 2024 in Journal Biomed
Verified
Journal Article
Open access
PDF file
ABA. A. Bondarenko
A. A. Bondarenko
TGT. L. Gorchakova
T. L. Gorchakova
ABA. Ya. Bespalov
A. Ya. Bespalov
LPL. I. Prokopenko
L. I. Prokopenko
PSP. D. Shabanov
P. D. Shabanov
This work presents the results of primary pharmacological screening of anticholinergic drugs and comparative evaluation of their specific activity in equitoxic concentrations using Daphnia magna Straus hydrobionts as a biological test object. We determine the protective index and the minimum effective concentration in terms of preventing atypical motor hyperactivity of pharmacological substances when poisoning with a reversible acetylcholinesterase inhibitor. On the basis of the results obtained, the list of promising candidates for further research in warm-blooded animals is extended by all of the anticholinergic drugs previously selected in experiments on mammals.